Savara raises $43M in follow-on

Rare respiratory disease company Savara Inc. (NASDAQ:SVRA) raised $43 million through the sale of 9 million shares at $4.75 in a follow-on underwritten by Jefferies, Canaccord Genuity and JMP Securit...